Melanóma: vizsgálatok itt: Franciaország

In Franciaország 61 Also abroad 578

61 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 11.. Ask the study team whether a trial fits you.

4. fázisTaking people
Dabrafenib and/or Trametinib Rollover Study
Where
Lyon, Nantes, Paris, Villejuif
Életkor
18 év to 100 év
People
100 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT03340506 · EU 2023-509318-13-00
No phaseTaking people
Blocking TNF to Potentiate the ICI-dependent Immune Awakening in Melanoma
Where
Toulouse
Életkor
18 év and over
People
100
Run by
Institut Claudius Regaud
See details and how to joinNCT05867004
1. fázisTaking people
Phase 1 Study of PF-08046033 in Advanced Solid Tumors
Where
Toulouse, Villejuif
Életkor
18 év and over
People
250 worldwide
Run by
Pfizer
See details and how to joinNCT07519655
2. fázisTaking people
A Study of Navlimetostat (BMS-986504) Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
Where
Dijon, Paris, Pierre-Bénite, Villejuif
Életkor
18 év and over
People
254 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT07492680
3. fázisTaking people
SUPRAME-ACTengine® IMA203 vs. Investigator's Choice of Treatment in Previously Treated, Unresectable or Metastatic Cutaneous Melanoma
Where
Lille, Paris, Villejuif
Életkor
18 év and over
People
450 worldwide
Run by
Immatics US, Inc.
See details and how to joinNCT06743126 · EU 2024-517062-42-00
2. fázisTaking people
DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
Where
Angers, Dijon, Lyon, Marseille, Paris, Poitiers, Saint-Herblain Cedex
Életkor
18 év and over
People
750 worldwide
Run by
DualityBio Inc.
See details and how to joinNCT06953089 · EU 2025-523895-22-00
No phaseNot yet taking people in Franciaország
Development of an Aid to Melanoma Detection Using Artificial Intelligence Algorithms Based on Images From the VECTRA 3D System.
Where
Marseille
Életkor
18 év and over
People
1000
Run by
Assistance Publique Hopitaux De Marseille
See details and how to joinNCT06999499
2. fázisTaking people
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Where
Bordeaux, Dijon, Lille, Lyon, Marseille, Nantes, Toulouse, Vandœuvre-lès-Nancy, Villejuif
Életkor
18 év and over
People
740 worldwide
Run by
Daiichi Sankyo
See details and how to joinNCT06172478 · EU 2023-507641-29-00
1/2. fázisTaking people
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
Where
Besancon Cedex, Bordeaux, Bordeaux Cedex, Dijon, Lyon, Montpellier Cedex 5, Paris, Rennes Cedex, Saint-Herblain Cedex, Toulouse Cedex 9, Villejuif
Életkor
18 év and over
People
680 worldwide
Run by
Daiichi Sankyo
See details and how to joinNCT06330064 · EU 2023-509632-26-00
No phaseTaking people
Predicting Response to Anti-PD-1/PD-L1 Immunotherapy by Plasma Extracellular Vesicle Analysis
Where
Besançon, Dijon, Lyon
Életkor
18 év and over
People
378
Run by
Centre Georges Francois Leclerc
See details and how to joinNCT07376512
2. fázisNot yet taking people in Franciaország
Neoadjuvant Pembrolizumab in Patients With High Risk, Stage IIB/IIC Cutaneous Melanoma: a Single Arm Proof of Concept Phase IIA Study.
Where
Besancon Cedex, Dijon
Életkor
18 év and over
People
19
Run by
Centre Hospitalier Universitaire de Besancon
See details and how to joinNCT07883759 · EU 2024-519573-19-00
2/3. fázisTaking people
Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.
Where
Bayonne, Bordeaux, Boulogne-Billancourt, Grenoble Cedex 9, Lille, Marseille, Nice, Paris Cedex 18, Pierre-Bénite, Rouen Cedex, Saint-Herblain Cedex, Strasbourg
Életkor
18 év and over
People
740 worldwide
Run by
Eikon Therapeutics
See details and how to joinNCT06697301 · EU 2024-512659-19-00
3. fázisTaking people
Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.
Where
Marseille, Nantes, Paris
Életkor
18 év to 70 év
People
670 worldwide
Run by
Iovance Biotherapeutics, Inc.
See details and how to joinNCT05727904 · EU 2022-503140-41-00
No phaseTaking people
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Where
Besançon, Levallois-Perret, Marseille, Neuilly, Paris
Életkor
18 év and over
People
2285 worldwide
Run by
Guardant Health, Inc.
See details and how to joinNCT05059444
1. fázisTaking people
A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
Where
Bordeaux, Caen, Lille, Lyon, Marseille, Nantes, Nice, Paris, Pierre-Bénite, Poitiers, Toulouse, Villejuif
Életkor
18 év and over
People
400 worldwide
Run by
Pierre Fabre Medicament
See details and how to joinNCT04913285
3. fázisCsak meghívásos
A Long-Term Follow-Up Study of Subjects Completing the AU-011-301(CoMpass) for Early Choroidal Melanoma
Where
Lyon Cedex 04, Nice
Életkor
18 év and over
People
100 worldwide
Run by
Aura Biosciences
See details and how to joinNCT07338968 · EU 2025-524405-33-00
1/2. fázisTaking people
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
Where
Villejuif
Életkor
18 év and over
People
366 worldwide
Run by
Marengo Therapeutics, Inc.
See details and how to joinNCT05592626 · EU 2023-505334-10-01
2. fázisNot yet taking people in Franciaország
Clinical Trial Evaluating the Biological Activity of a New Drug Identified as Prifetrastat (PF-07248144), Combined With Fulvestrant for the Treatment of Patients With Hormone Receptor Positive (HR+) and HER2 Negative (HER2-) Breast Cancer Extended to Other Organs.
Where
Bordeaux, Lyon, Marseille, Nice Cedex 2, Paris, Rennes Cedex, Saint-Herblain Cedex, Toulouse Cedex 9, Villejuif
Életkor
18 év and over
People
51
Run by
UNICANCER
See details and how to joinNCT07340619 · EU 2025-521982-29-00
No phaseTaking people
Impact of Physical Activity on Immunotherapy-induced Toxicities in Melanoma Management
Where
Montpellier
Életkor
18 év and over
People
160
Run by
University Hospital, Montpellier
See details and how to joinNCT06627595
2. fázisTaking people
Neo-adjuvant Immunotherapy in Patients With Localized Melanoma
Where
Bordeaux, Lyon, Marseille, Paris, Villejuif
Életkor
18 év and over
People
50
Run by
UNICANCER
See details and how to joinNCT07230613
3. fázisTaking people
VO and Nivolumab vs Physician's Choice in Advanced Melanoma That Progressed on Anti-PD-1 & Anti-CTLA-4 Drugs [IGNYTE-3]
Where
Bordeaux Cedex, Lille, Marseille, Nice, Paris, Pierre-Bénite, Villejuif
Életkor
12 év and over
People
400 worldwide
Run by
Replimune, Inc.
See details and how to joinNCT06264180 · EU 2023-508612-29-00
1/2. fázisTaking people
A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)
Where
Paris, Villejuif
Életkor
6 hónap to 17 év
People
370 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT02332668 · EU 2022-501257-36-00
1/2. fázisTaking people
A phase 1/2a, first-in-human, open-label, dose-escalating study with a safety expansion cohort to evaluate safety, tolerability, pharmacokinetics, pharmacodynamics and preliminary anti-tumour activity of TAX2 in patients with relapsed/refractory advanced/metastatic solid tumours
Where
Lyon, Villejuif
Életkor
18 év and over
People
48 worldwide
Run by
Apmonia Therapeutics
See details and how to join2025-521164-36-00 · EU 2025-521164-36-00
3. fázisTaking people
Adjuvant Tebentafusp in High Risk Ocular Melanoma
Where
Clermont Ferrand Cedex1, Nice Cedex 2, Paris, Rennes Cedex
Életkor
18 év and over
People
290 worldwide
Run by
European Organisation for Research and Treatment of Cancer - EORTC
See details and how to joinNCT06246149 · EU 2023-510333-28-00
No phaseTaking people
COmparison of the Use of a PERforator Flap Versus Total Skin GRAft in the Management of Loss of Substance After Resection of Cutaneous Melanoma - Pilot Study
Where
Nantes
Életkor
18 év and over
People
40
Run by
Nantes University Hospital
See details and how to joinNCT07354152